WMT

123

+0.69%↑

COST

983.15

+0.34%↑

142.7

+0.27%↑

75.67

+1.27%↑

163.6

+0.66%↑

WMT

123

+0.69%↑

COST

983.15

+0.34%↑

142.7

+0.27%↑

75.67

+1.27%↑

163.6

+0.66%↑

WMT

123

+0.69%↑

COST

983.15

+0.34%↑

142.7

+0.27%↑

75.67

+1.27%↑

163.6

+0.66%↑

WMT

123

+0.69%↑

COST

983.15

+0.34%↑

142.7

+0.27%↑

75.67

+1.27%↑

163.6

+0.66%↑

WMT

123

+0.69%↑

COST

983.15

+0.34%↑

142.7

+0.27%↑

75.67

+1.27%↑

163.6

+0.66%↑

Home・Akcijų sąrašas・Compass Pathways Plc ADR

Compass Pathways Plc ADR

Uždarymo kaina

5.35 -4.8

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

5.3

Max

5.62

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-99M -138M
Pelnas, tenkantis vienai akcijai	-0.384
Darbuotojai	166
EBITDA	-95M -137M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+305.03% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-05-07

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	35M 606M
Ankstesnė atidarymo kaina	10.15
Ankstesnė uždarymo kaina	5.35

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bearish Evidence

3.645 / 4.0539 Palaikymas ir pasipriešinimas

Compass Pathways Plc ADR Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-27 17:33; UTC

Svarbiausios naujienos

ECB Should Not Rush Its Response to Iran Conflict, Says Schnabel -- Update

2026-03-27 17:00; UTC

Svarbiausios naujienos

ECB Shouldn't Rush Its Response to Iran Conflict, Schnabel Says

2026-03-27 16:03; UTC

Svarbiausios naujienos

Fertilizer Maker Yara Warns Farmers Are Being Squeezed by Price Surge Amid War -- Commodities Roundup

2026-03-27 14:50; UTC

Pagrindinės rinkos jėgos

Cybersecurity Stocks Fall on Leak About New Claude Model's Cyber Capabilities

2026-03-27 14:37; UTC

Įsigijimai, susijungimai, perėmimai

Nestle's Water Business Stake Sale Could Value Unit at Around $5.76 billion, FT Says, Citing Sources

2026-03-27 14:29; UTC

Svarbiausios naujienos

EU Finance Ministers Tally Economic Hit of Iran War -- Update

2026-03-27 14:16; UTC

Svarbiausios naujienos

The Week in Oil: Mixed Signals Over U.S.-Iran Talks Keep Traders Wary

2026-03-27 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-27 19:16; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Futures Rise On Uncertainty Ahead of Weekend -- Market Talk

2026-03-27 19:07; UTC

Rinkos pokalbiai

U.S. Natural Gas Gains As April Contract Expires -- Market Talk

2026-03-27 19:04; UTC

Rinkos pokalbiai

Gold Rises But Can't Finish the Week Positive -- Market Talk

2026-03-27 19:03; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Global Forex and Fixed Income Roundup: Market Talk

2026-03-27 19:02; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Among Central Banks, Canada Has Room to Handle Oil Inflation -- Market Talk

2026-03-27 18:12; UTC

Rinkos pokalbiai

Foreign Fuels and Feedstocks to Get RINs Until 2028 -- Market Talk

2026-03-27 17:36; UTC

Svarbiausios naujienos

The Iran War and Oil Prices Bring Risk of Deeper Market Lows. There Are Echoes of 2008. -- Barrons.com

2026-03-27 17:34; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Delivery Hero Shares Bounce as Stake-Sale Report Whets Investor Appetites -- Market Talk

2026-03-27 17:29; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Falls By 5 to 409 -- Market Talk

2026-03-27 16:38; UTC

Rinkos pokalbiai

Carnival's Outlook Assumes Oil Prices Will Come Down -- Market Talk

2026-03-27 16:32; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Chinese Exposure to Higher Energy Costs Seen as Limited -- Market Talk

2026-03-27 16:20; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-27 15:43; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Hormuz Closure Sends Tanker Rates to Record Highs -- Market Talk

2026-03-27 15:25; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-27 15:25; UTC

Rinkos pokalbiai

Swiss Franc Dented by Rising European Yields, SNB Intervention Threats -- Market Talk

2026-03-27 15:00; UTC

Svarbiausios naujienos

Fed's Barkin: Inflation Progress 'May Be at Risk of Stalling'

2026-03-27 15:00; UTC

Svarbiausios naujienos

Fed's Barkin: Holding Rates Steady in March 'Felt Prudent'

2026-03-27 15:00; UTC

Svarbiausios naujienos

Fed's Barkin Says Iran War Raising Economic Uncertainty

2026-03-27 14:36; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Rising Yields, Oil Prices Seen as Overreaction -- Market Talk

2026-03-27 14:26; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Treasury Yields Mixed as Iran Peace Deal Remains Elusive -- Market Talk

2026-03-27 14:14; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-27 14:14; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Compass Pathways Plc ADR Prognozė

Kainos tikslas

By TipRanks

305.03% į viršų

12 mėnesių prognozė

Vidutinis 21.75 USD 305.03%

Aukščiausias 70 USD

Žemiausias 8 USD

Remiantis 12 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Compass Pathways Plc ADR kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

12 ratings

Pirkti

Laikyti

Parduoti

Remiantis 12 analitikų, pateikusių Compass Pathways Plc ADR akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

3.645 / 4.0539Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

All events are bullish.

There are no events.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Compass Pathways Plc ADR

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.